跳至主要内容
临床试验/NCT06626074
NCT06626074招募中不适用

Exploratory Study of MRI Biomarkers of NASH

University Hospital, Angers3 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2025年9月5日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
110
试验地点
3
主要终点
Evaluation of the diagnostic performance of new MRI biomarkers for NASH diagnosis

研究概览

简要总结

Metabolic steatosis disease (NAFLD) is a rapidly growing disease in the world, particularly in industrialized countries.

NAFLD is defined by the presence of fatty liver disease. This is a reversible phenomenon that can be estimated by non-invasive means, such as ultrasound. Non-invasive quantification, on the other hand, requires MRI.

Nonalcoholic steatohepatitis (NASH) is the aggressive form of the disease that promotes the accumulation of fibrosis in the liver, which can progress to cirrhosis and its complications.

Currently there is no non-invasive biomarker of NASH and the diagnosis is based solely on liver biopsy.

There is therefore a need for non-invasive biomarkers of NASH in patients with steatosis to diagnose NASH without the use of liver biopsy.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient included in the SNIFF cohort of the Angers hospital where there is a suspicion of NASH requiring a biopsy for which an MRI is requested by a hepatologist as part of the initial assessment of the disease.
  • Adult patient
  • Free, informed and express (oral) consent of the patient to participate in the study

排除标准

  • Contraindication to MRI
  • Time between the establishment of the Steatosis/NASH status and the MRI greater than 3 months
  • Pregnant, parturient and breastfeeding woman
  • Person deprived of liberty by judicial or administrative decision
  • Person under compulsion to psychiatric care
  • Person subject to a legal protection measure
  • Person not affiliated or not covered by a social security scheme.

研究组 & 干预措施

Open label

Experimental

干预措施: Quantitative MRI sequences (Device)

结局指标

主要结局

Evaluation of the diagnostic performance of new MRI biomarkers for NASH diagnosis

时间窗: the outcome measurment is performed once during MRI

NASH is defined by histological criteria

次要结局

未报告次要终点

研究者

发起方
University Hospital, Angers
申办方类型
Other Gov
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验